Trans fatty acids and coronary heart disease

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7561.214 (Published 27 July 2006)
Cite this as: BMJ 2006;333:214

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Robert Clarke (robert.clarke@ctsu.ox.ac.uk), honorary consultant in public health medicine,
  2. Sarah Lewington, senior research fellow
  1. Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, University of Oxford, Oxford OX3 7LF
  2. Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, University of Oxford, Oxford OX3 7LF

    Food labels should list these as well as cholesterol and saturated fat

    Arecent systematic review by Mozaffarian and colleagues in the New England Journal of Medicine advocated that people should reduce or stop their dietary intake of trans fatty acids to minimise the related risk of coronary heart disease.1 Trans fatty acids—unsaturated fatty acids with at least one double bond in the trans molecular configuration—are produced by partial hydrogenation of vegetable oils. This is a process that converts vegetable oils into semisolid fats which have no known nutritional value but are widely used in margarines, in commercial cooking, and in manufactured foods.2

    Reliable evidence for the effects of trans fatty acids and other types of fat on blood lipids comes from …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL